![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Fiore Simona Savasi Valeria
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.10, Iss.17, 2009-12, pp. : 2801-2809
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Evolving therapies for the treatment of viral hepatitis
Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of viral hepatitis B in children
By Giacchino Raffaella Cappelli Barbara
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Zadaxin (thymosin 1) for the treatment of viral hepatitis
By Naylor P.H.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. :